Trial Profile
Phase 3 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers: A Randomized, Placebo-controlled, Double-blind, Parallel-group, Multi-center Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Aug 2023
Price :
$35
*
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Diabetic foot ulcer
- Focus Registrational; Therapeutic Use
- Sponsors Anterogen
- 24 Aug 2023 Status changed from active, no longer recruiting to completed.
- 21 Jan 2021 Planned End Date changed from 30 Sep 2019 to 30 Jun 2021.
- 21 Jan 2021 Planned primary completion date changed from 30 Jun 2019 to 30 Jun 2021.